Mulmit

Lineage Cell Therapeutics, Inc.Lineage Cell Therapeutics, Inc.

LCTX NYSE

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3114,556,000-36,619,000-63,533,000-0.28
2024-12-319,499,000-21,478,000-18,609,000-0.09
2023-12-318,945,000-24,733,000-21,486,000-0.12
2022-12-3114,703,000-22,520,000-26,273,000-0.15
2021-12-314,341,000-49,211,000-43,019,000

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-07-01Jayasuriya Anula125,000
2026-07-01Mulroy Michael H.125,000
2026-07-01ANDREWS DEBORAH J125,000
2026-07-01Russell Angus C.125,000
2026-07-01Amin Dipti125,000
2026-07-01Bradsher Neal C125,000
2026-03-12Culley Brian MPresident and CEO15,000
2026-03-05Culley Brian MPresident and CEO3,250,000
2026-03-05Howe Jill AnnChief Financial Officer1,050,000
2026-03-05Samuel George A. IIIGeneral Counsel and Secretary900,000
2026-02-11Culley Brian MPresident and CEO31,250
2026-02-11Culley Brian MPresident and CEO12,869

8-K events

FiledItems
2026-08-06Results of operations · Financial statements and exhibits
2026-06-12Submission of matters to a vote · Other events
2026-05-12Results of operations · Financial statements and exhibits
2026-03-11Other events · Financial statements and exhibits
2026-03-05Results of operations · Financial statements and exhibits
2025-11-28Other events
2025-11-24Other events
2025-11-12Other events
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.